Brind.
  1. Abbott Laboratories is discussing the acquisition of Synlait's Pokeno facility and considering other facilities in New Zealand.

An article details how the company Synlait operates in New Zealand, including its assets and majority shareholder structure.

1 report, 1 independent Updated Jul 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

An article details how the company Synlait operates in New Zealand, including its assets and majority shareholder structure.

Who's involved

What this event is mainly about
SynlaitChristchurch

Keep exploring

Part of

Abbott Laboratories is discussing the acquisition of Synlait's Pokeno facility and considering other facilities in New Zealand. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped